| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0306-9877(96)90071-7 |
| P698 | PubMed publication ID | 8910880 |
| P2093 | author name string | Ying W | |
| P2860 | cites work | Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis | Q24306886 |
| Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 | ||
| Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis | Q28335672 | ||
| Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation | Q29547561 | ||
| Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia | Q33322579 | ||
| Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis | Q34300016 | ||
| Excitatory amino acids as a final common pathway for neurologic disorders. | Q34321926 | ||
| Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid | Q34384772 | ||
| Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? | Q35254212 | ||
| The oxidant stress hypothesis in Parkinson's disease: evidence supporting it | Q35626743 | ||
| Calcium as sculptor and destroyer of neural circuitry | Q35680713 | ||
| IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer | Q36724305 | ||
| Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease | Q36760254 | ||
| Oxygen radicals and neuropsychiatric illness. Some speculations | Q37152812 | ||
| What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies | Q37578887 | ||
| Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? | Q37936915 | ||
| Bioenergetic and oxidative stress in neurodegenerative diseases | Q40369216 | ||
| Age-related changes in cerebral oxidative metabolism. Implications for drug therapy. | Q40450162 | ||
| Aging, energy, and oxidative stress in neurodegenerative diseases. | Q40478731 | ||
| Amyotrophic lateral sclerosis is a multifactorial disease | Q40546531 | ||
| Ion transport systems and Ca2+ regulation in aging neurons. | Q40586893 | ||
| Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice | Q40612435 | ||
| Magnesium and Calcium Contents in CNS Tissues of Amyotrophic Lateral Sclerosis Patients from the Kii Peninsula, Japan | Q41083434 | ||
| Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists | Q41154685 | ||
| The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis | Q41413618 | ||
| Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin | Q41458956 | ||
| Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam | Q41624368 | ||
| Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients | Q41652065 | ||
| Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells | Q41843416 | ||
| Striatal deficiency of L-pyroglutamic acid in Huntington's disease is accompanied by increased plasma levels | Q42204389 | ||
| Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease | Q42506358 | ||
| Deleterious network hypothesis of Alzheimer's disease | Q44245798 | ||
| Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d,l-HMPAO SPECT study | Q44254770 | ||
| Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease | Q44480462 | ||
| Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence | Q44498466 | ||
| Muscle lactate dehydrogenase activity is decreased in murine motor neuron disease | Q44580826 | ||
| Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats | Q44848373 | ||
| Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. | Q44934024 | ||
| Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization | Q45291026 | ||
| Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases | Q45293874 | ||
| The mechanism of glutamate-induced degeneration of cultured Huntington's disease and control fibroblasts | Q45296572 | ||
| Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity | Q46070812 | ||
| Point mutations of mitochondrial genome in Parkinson's disease | Q48075275 | ||
| An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease | Q48184003 | ||
| NMDA-dependent superoxide production and neurotoxicity | Q48234286 | ||
| Parkinson's disease and basal ganglia calcifications: prevalence and clinico-radiological correlations | Q52046704 | ||
| An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria | Q54965159 | ||
| Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: Evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS | Q57540072 | ||
| Oxidative damage to protein in sporadic motor neuron disease spinal cord | Q59544371 | ||
| Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease | Q59544375 | ||
| Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease | Q71694543 | ||
| A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis | Q71894900 | ||
| Toward an understanding of the role of glutamate in experimental parkinsonism: Agonist‐sensitive sites in the basal ganglia | Q72100592 | ||
| Decrease in Cu/Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis | Q72116629 | ||
| Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors | Q72209261 | ||
| Parkinson's disease: a test of the multifactorial etiologic hypothesis | Q72391740 | ||
| Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis | Q72529952 | ||
| Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis | Q72621641 | ||
| Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis | Q72663413 | ||
| A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group | Q72759362 | ||
| P433 | issue | 4 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| deleterious network hypothesis | Q108305420 | ||
| P304 | page(s) | 307-313 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | Medical Hypotheses | Q5558534 |
| P1476 | title | A new hypothesis of neurodegenerative diseases: the deleterious network hypothesis. | |
| P478 | volume | 47 |
| Q44179098 | Chemotherapeutically induced deletion of expanded triplet repeats |
| Q73168807 | Deleterious network hypothesis of aging |
| Q74817365 | Deleterious network hypothesis of apoptosis |
| Q63341579 | Evaluation of free radical production, mitochondrial membrane potential and cytoplasmic calcium in mammalian neurons by flow cytometry |
| Q83728053 | Huntington's Disease |
| Q38151200 | Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms |
| Q89880514 | Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies |
| Q37015565 | NAD+ and NADH in neuronal death |
| Q36090617 | Oxidative stress and NAD+ in ischemic brain injury: current advances and future perspectives |
| Q23920334 | Potential occupational risks for neurodegenerative diseases |
| Q35120158 | Serum containing Tongqiaohuoxue decoction suppresses glutamate-induced PC12 cell injury |
| Q44924668 | Toxic effect of chloromycetin on the ultrastructures of the motor neurons of the Chinese tree shrew (Tupaia belangeri). |
Search more.